FFCP PHASE1:Mm9::chr12:81332459..81332485,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=3|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr12:81332459..81332485,-|id=chr12:81332459..81332485,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=CL:0000355,2.31e-13,9|ontology_enrichment_disease=DOID:0060100!5.17e-13!3;DOID:4045!5.17e-13!3|ontology_enrichment_disease_v019_2=DOID:0060100,2.09e-38,3;DOID:4045,2.09e-38,3;DOID:0050686,1.19e-19,6|ontology_enrichment_uberon=|ontology_enrichment_uberon_v019_2=UBERON:0001134,2.31e-13,9;UBERON:0002036,2.31e-13,9;UBERON:0002385,2.31e-13,9;UBERON:0000486,2.31e-13,9;UBERON:0007503,2.31e-13,9;UBERON:0001015,2.31e-13,9;UBERON:0002329,2.31e-13,9;UBERON:0003082,2.31e-13,9;UBERON:0003059,2.31e-13,9;UBERON:0007282,2.31e-13,9;UBERON:0004290,2.31e-13,9;UBERON:0009618,2.31e-13,9;UBERON:0000383,4.23e-12,10;UBERON:0007524,4.59e-11,11;UBERON:0003077,4.59e-11,11;UBERON:0007285,4.59e-11,11|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202475267389826,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.221730510655305,0,0,0,0,0,0,13.811543814318,7.813353445238,7.85285615960697,12.9410927366823,4.09827290975067,5.82612423637384,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.173485326766136,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.201683524623343,0,0,0,0,0,0,0,0,0,0.199141273254367,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.241177159752417,0.25462585178142,0,0,0,1.43768206527355,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.172684981865896,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.206386867963223,0,0,0,0,0,0.139951452323658,0.138199973804424,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.100966449948148,0.0762068066549998,0,0,0,0,0,0,0,0,0,0,0,0.214368379079066,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.238436189947321,0.145346416632329,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.220591419119515,0|short_description=p@chr12:81332459..81332485,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=3 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr12:81332459..81332485,- | |||
|description=CAGE_peak_at_chr12:81332459..81332485,- | |||
|id=chr12:81332459..81332485,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,2.31e-13,9 | |||
|ontology_enrichment_disease=DOID:0060100!5.17e-13!3;DOID:4045!5.17e-13!3 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,2.09e-38,3;DOID:4045,2.09e-38,3;DOID:0050686,1.19e-19,6 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,2.31e-13,9;UBERON:0002036,2.31e-13,9;UBERON:0002385,2.31e-13,9;UBERON:0000486,2.31e-13,9;UBERON:0007503,2.31e-13,9;UBERON:0001015,2.31e-13,9;UBERON:0002329,2.31e-13,9;UBERON:0003082,2.31e-13,9;UBERON:0003059,2.31e-13,9;UBERON:0007282,2.31e-13,9;UBERON:0004290,2.31e-13,9;UBERON:0009618,2.31e-13,9;UBERON:0000383,4.23e-12,10;UBERON:0007524,4.59e-11,11;UBERON:0003077,4.59e-11,11;UBERON:0007285,4.59e-11,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202475267389826,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.221730510655305,0,0,0,0,0,0,13.811543814318,7.813353445238,7.85285615960697,12.9410927366823,4.09827290975067,5.82612423637384,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.173485326766136,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.201683524623343,0,0,0,0,0,0,0,0,0,0.199141273254367,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.241177159752417,0.25462585178142,0,0,0,1.43768206527355,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.172684981865896,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.206386867963223,0,0,0,0,0,0.139951452323658,0.138199973804424,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.100966449948148,0.0762068066549998,0,0,0,0,0,0,0,0,0,0,0,0.214368379079066,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.238436189947321,0.145346416632329,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.220591419119515,0 | |||
|short_description=p@chr12:81332459..81332485,- | |||
}} |
Latest revision as of 08:00, 5 August 2015
Short description: | p@chr12:81332459..81332485, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr12:81332459..81332485, - |
Coexpression cluster: | MCL_coexpression_mm9:3 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 2.31e-13 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 2.31e-13 | 9 |
striated muscle tissue | 2.31e-13 | 9 |
muscle tissue | 2.31e-13 | 9 |
multilaminar epithelium | 2.31e-13 | 9 |
epithelial vesicle | 2.31e-13 | 9 |
musculature | 2.31e-13 | 9 |
somite | 2.31e-13 | 9 |
myotome | 2.31e-13 | 9 |
presomitic mesoderm | 2.31e-13 | 9 |
presumptive segmental plate | 2.31e-13 | 9 |
dermomyotome | 2.31e-13 | 9 |
trunk paraxial mesoderm | 2.31e-13 | 9 |
musculature of body | 4.23e-12 | 10 |
dense mesenchyme tissue | 4.59e-11 | 11 |
paraxial mesoderm | 4.59e-11 | 11 |
presumptive paraxial mesoderm | 4.59e-11 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 2.09e-38 | 3 |
muscle cancer | 2.09e-38 | 3 |
organ system cancer | 1.19e-19 | 6 |